Scheduled to launch at the end of September under the All-Q brand, the new product uses a starch-based powder as a carrier for 10 per cent purity CoQ10.
It could be formulated into water-based beverages, dairy products or energy drinks, suggests the company.
CoQ10 is believed to help cells convert oxygen into energy and function efficiently. Recent studies indicating that it could aid cardiovascular health and help slow the progression of Parkinson's disease have triggered a huge surge in demand.
At around €300 per kg for the new DSM product, it is more expensive than the crystalline version, which has dropped in price since peaking earlier this year as a result of tight demand.
But the firm is promising numerous advantages.
DSM has already introduced the 10 per cent CoQ10 in a poultry gelatine beadlet that makes it significantly easier to handle for supplement makers than the more typical crystalline form.
Prior to the US launch of the product in March and this month's launch for the European market, supplement makers used CoQ10 crystals suspended in oil and then encapsulated in soft gelatine capsules.
However the new powder made by DSM's Nutritional Products unit (www.dsm.com ) makes the antioxidant ingredient suitable for tabletting, increasing its use in multivitamins and other tablets.
The leading vitamin maker is also promising tabletters low extrusion loss - the amount of active substance that is squeezed out of the blended ingredients during pressing of the tablets - giving the manufacturer more active in the tablet and less waste.
Lynda Doyle, DSM's director of business development, said that competing brands experienced 100 percent extrusion loss, compared with just 1.9 percent for all-Q.
Further, both the tablet-grade and food-grade CoQ10 are more bioavailable than the almost 100 per cent purity crystalline form thanks to the new carriers, despite being only 10 per cent purity, says Peter Schuler, responsible for the product's launch at Food Ingredients Europe later this year.
A study comparing the bioavailability of the product with Q-Gels and Q-Sorb will be published in the Journal of Medicinal Food (vol 8, issue 3).
Tested in 12 healthy men, the randomized, three period cross-over trial compared 120mg of ALl-Q CoQ10 with the same dose in a Q-Gel formulation and Q-Sorb.
